Carrington Reports Second Quarter 20...(ing - Basic and diluted 109...)

Basic and diluted 10,909 10,836 10,905 10,823

Reconciliation of

Non-GAAP Financial

Measures:

Net income (loss): $(2,213) $(2,155) $(4,843) $(3,687)

Less: DelSite grant income 398 352 622 695

Plus: DelSite expenses 1,199 1,325 2,275 2,481

Pro forma profit (loss)

before DelSite $(1,412) $(1,182) $(3,190) $(1,901)

CARRINGTON LABORATORIES, INC.

Condensed Consolidated Balance Sheets

(in thousands)

June 30, December 31,

2007 2006

(unaudited) (audited)

ASSETS:

Current Assets:

Cash and cash equivalents $661 $878

Cash, restricted 200 -

Accounts receivable, net 2,888 2,659

Inventories, net 3,883 3,405

Prepaid expenses 394 155

Total current assets 8,026 7,097

Property, plant and equipment, net 5,694 6,093

Customer relationships, net 103 199

Other assets, net 1,291 609

Total assets $15,114 $13,998

LIABILITIES AND SHAREHOLDERS' EQUITY:

Current Liabilities:

Line of credit $2,000 $1,811

Accounts payable 2,876 1,324

Accrued liabilities 1,296 1
'/>"/>

SOURCE Carrington Laboratories, Inc. Copyright©2007 PR Newswire.

0 GOOD